| Finding the dose for hydroxychloroquine prophylaxis for COVID‐19: the desperate search for effectiveness M Al‐Kofahi, P Jacobson, DR Boulware, A Matas, R Kandaswamy, ... Clinical Pharmacology & Therapeutics 108 (4), 766-769, 2020 | 66 | 2020 |
| An integrated PK‐PD model for cortisol and the 17‐hydroxyprogesterone and androstenedione biomarkers in children with congenital adrenal hyperplasia M Al‐Kofahi, MA Ahmed, MM Jaber, TN Tran, BA Willis, CL Zimmerman, ... British Journal of Clinical Pharmacology, 2020 | 20 | 2020 |
| Seasonal influenza vaccination among older adults in Jordan: prevalence, knowledge, and attitudes M Ababneh, M Jaber, A Rababa’h, F Ababneh Human vaccines & immunotherapeutics 16 (9), 2252-2256, 2020 | 17 | 2020 |
| Manipulation of hydrocortisone tablets leads to iatrogenic Cushing syndrome in a 6-year old girl with CAH H Al-Rayess, K Fleissner, M Jaber, RC Brundage, K Sarafoglou Journal of the Endocrine Society 4 (8), 1-11, 2020 | 15 | 2020 |
| CYP2C19 phenotype and body weight-guided voriconazole initial dose in infants and children after hematopoietic cell transplantation T Takahashi, MA Mohamud, AR Smith, PA Jacobson, MM Jaber, ... Antimicrobial agents and chemotherapy 65 (9), 10.1128/aac. 00623-21, 2021 | 14 | 2021 |
| Predictive Value of C‐Reactive Protein and Albumin for Temporal Within‐Individual Pharmacokinetic Variability of Voriconazole in Pediatric Patients Undergoing Hematopoietic … T Takahashi, MM Jaber, AR Smith, PA Jacobson, J Fisher, MN Kirstein The Journal of Clinical Pharmacology 62 (7), 855-862, 2022 | 6 | 2022 |
| Prevalence of antimicrobial use in a tertiary academic hospital: a venue for antimicrobial stewardship programs MA Ababneh, M Jaber, A Rababa’h, E Alabweny Expert Review of Anti-Infective Therapy 19 (8), 1047-1051, 2021 | 5 | 2021 |
| Individualized absorption models in population pharmacokinetic analyses MM Jaber, M Al‐Kofahi, K Sarafoglou, RC Brundage CPT: Pharmacometrics & Systems Pharmacology 9 (6), 307, 2020 | 5 | 2020 |
| Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events T Takahashi, M Al-Kofahi, M Jaber, B Bratrude, K Betz, Y Suessmuth, ... Blood 142 (8), 700-710, 2023 | 4 | 2023 |
| Application of deep neural networks as a prescreening tool to assign individualized absorption models in pharmacokinetic analysis MM Jaber, B Yaman, K Sarafoglou, RC Brundage Pharmaceutics 13 (6), 797, 2021 | 2 | 2021 |
| Evaluation of bias in weighted residual calculations when handling below the limit of quantification data using Beal’s M3 method MM Jaber, S Cheng, RC Brundage CPT: Pharmacometrics & Systems Pharmacology 10 (4), 275, 2021 | 2 | 2021 |
| Population pharmacokinetics of total rabbit anti-thymocyte globulin in non-obese adult patients undergoing hematopoietic cell transplantation for hematologic malignancy T Takahashi, M Teramoto, K Matsumoto, MM Jaber, H Tamaki, K Ikegame, ... Clinical Pharmacokinetics 62 (8), 1081-1091, 2023 | 1 | 2023 |
| Population Pharmacokinetic Model of Intravenous Busulfan in Hematopoietic Cell Transplantation: Systematic Review and Comparative Simulations T Takahashi, MM Jaber, SJ Brown, M Al-Kofahi Clinical Pharmacokinetics 62 (7), 955-968, 2023 | 1 | 2023 |
| Case Report: Anastrozole as a monotherapy for pre-pubertal children with non-classic congenital adrenal hyperplasia SC Liu, M Suresh, M Jaber, Y Mercado Munoz, K Sarafoglou Frontiers in Endocrinology 14, 1101843, 2023 | 1 | 2023 |
| Influence of Renal Function on Phosphoramide Mustard Exposure: A Nonlinear Mixed‐Effects Analysis MM Jaber, T Takahashi, MN Kirstein, M Al‐Kofahi, PA Jacobson, ... The Journal of Clinical Pharmacology 63 (1), 135-142, 2023 | 1 | 2023 |
| Comparison of Dose Adjustment Strategies for Obesity in High-dose Cyclophosphamide Among Adult Hematopoietic Cell Transplantation Recipients: Pharmacokinetic Analysis T Takahashi, MM Jaber, M Al-Kofahi, D Weisdorf, C Brunstein, ... Transplantation and Cellular Therapy 28 (12), 845. e1-845. e8, 2022 | 1 | 2022 |
| Bone age maturation and growth outcomes in young children with cah treated with hydrocortisone suspension H Al-Rayess, OY Addo, E Palzer, M Jaber, K Fleissner, J Hodges, ... Journal of the Endocrine Society 6 (2), bvab193, 2022 | 1 | 2022 |
| Hydrocortisone suspension formulations are not necessarily the same in the treatment of children with congenital adrenal hyperplasia K Sarafoglou, MM Jaber, M Al-Kofahi, RC Brundage European Journal of Endocrinology 183 (6), L27-L28, 2020 | 1 | 2020 |
| Individualized rabbit anti‐thymocyte globulin dosing in adult haploidentical hematopoietic cell transplantation with high‐risk hematologic malignancy: Exposure–response … M Teramoto, T Takahashi, K Matsumoto, M Jaber, K Kaida, H Tamaki, ... American Journal of Hematology 99 (3), 387-395, 2024 | | 2024 |
| Sex Non-Specific Growth Charts and Potential Clinical Implications in the Care of Transgender Youth and Rare Disease Populations E Bomber, L Golob, B Miller, Y Addo, A Rogol, M Jaber, K Sarafoglou HORMONE RESEARCH IN PAEDIATRICS 96, 325-326, 2023 | | 2023 |
Mahmoud Al-KofahiSr. Clinical Pharmacologist I, Gilead SciencesVerified email at gilead.com
